Obesity Flashcards
Central body weight regulation
————of the hypothalamus, Regulates appetite, feeding behavior and energy status
Arcuate nucleus (ARC)
The Arcuate Nucleus (ARC) Receives afferent inputs originating from the ———
GI tract
Arcuate nucleus (ARC) Contains receptors for ——- and other hormones
Leptin
fxn: inhibits hunger and regulates energy balance (so that the body doesn’t trigger a hunger response when it doesn’t need energy -calories)
In the ARC, there are two groups of functionally distinct neurons that exert opposite effects on appetite
1) ——— (appetite supressing)
2) ——– (appetite promoting)
1) Anorexigenic (appetite supressing)
2) Orexigenic neurons (appetite promoting)
Anorexigenic nerurons (appetite supressing)
activate what to supress appetite?
1) Pro-opiomelanocortin (POMC)-derived peptides (such as αmelanocyte-stimulating hormone; α-MSH)
2) Cocaine- and amphetamine-regulated transcript (CART)-derived peptides
Orexigenic neurons (appetite promoting), activate what to trigger hunger ?
1) Neuropeptide Y (NPY)
2) Agouti-related peptide (AgRP)
Energy homeostasis depends on the balance between
the actions of —— and ——– in the Arcuate nucleus
Energy homeostasis depends on the balance between
the actions of Anorexigenic neurons and Orexigenic neurons in the Arcuate nucleus
1st line tx for Obesity
GLP1-mimetics (Liraglutide)
2nd line tx for Obesity
Orlistate (when GLP-1 mimetic are not effective/well-tolerated)
3rd line tx for Obesity
Phentermine (Centrally acting drug)
Centrally acting drugs
Phentermine
topiramate
Naltrexon
Bupropion
MoA of Phentermine
Sympathomimetic amine
anorectic effects in hypothalamus and limbic areas of the brain
–> Increases the release of norepinephrine and dopamine (DA) -> increased POMC/CART neuron activity
SOOO, SUPRESES APPETITE
MoA of Topiramate
Anti-epileptic drug that possibly suppresses appetite and enhances satiety
MoA of Bupropion
Increases DA activity in the brain –>reduction in appetite and increase in energy expenditure by increased POMC neuron activity
MoA of Naltrexon
Blocks opioid receptors on POMC neurons–> preventing feedback inhibition of these neurons with
increased POMC activity